LifeMD
LFMD
52 hedge funds and large institutions have $25.1M invested in LifeMD in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 3 closing their positions.
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
160% more capital invested
Capital invested by funds: $9.65M → $25.1M (+$15.5M)
43% more call options, than puts
Call options by funds: $290K | Put options by funds: $203K
21% more funds holding
Funds holding: 43 → 52 (+9)
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
0.01% more ownership
Funds ownership: 17.79% → 17.8% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
+$1.06M |
| 2 |
GIPM
G2 Investment Partners Management
New York
|
+$472K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$288K |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$224K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$199K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shah Capital Management
Raleigh,
North Carolina
|
-$1.02M |
| 2 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$1.02M |
| 3 |
JP Morgan Chase
New York
|
-$151K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$143K |
| 5 |
RA
Royce & Associates
New York
|
-$111K |
LFMD Hedge Fund Activity: Q2 2023 in Review
52 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q2 2023, worth a combined $25.1M — up 160% from $9.65M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new LFMD positions and 3 closed out — a net gain of 9 holders — while 15 added to existing stakes and 14 trimmed.
The largest buyer was EAM Investors, opening a new position worth an estimated $1.06M. The largest seller was Shah Capital Management, cutting an estimated $1.02M.
- 52 institutional investors held LifeMD (LFMD) as of Q2 2023, up from 43 in Q1 2023.
- Funds reported $25.1M of LifeMD stock for Q2 2023, up 160% quarter-over-quarter.
- 12 funds opened new LifeMD positions in Q2 2023 and 3 closed out, a net change of +9 holders.
- The largest LifeMD buyer in Q2 2023 was EAM Investors, an estimated $1.06M added.
- The largest LifeMD seller in Q2 2023 was Shah Capital Management, an estimated $1.02M sold.
Based on aggregated 13F filings for Q2 2023.